Our privacy policy describes how Fidessa uses cookies on our website. If you continue using our website, you are consenting to our use of cookies. OK

If it ain’t broke, break it

I was hoping to enjoy the last few weeks of summer in relative peace, but it seems that another regulatory storm is brewing. This time it’s over the unbundling of research and it all stems from ESMA’s interpretation that, under MiFID II, research is an “inducement to trade” and therefore cannot be paid for out of commissions. This threatens to completely derail the economics of trading and reduce the quantity and quality of research available (and the resultant investment decisions). The current approach allows for research and other legitimate broker services to be paid for out of dealing commission and is managed and controlled via commission sharing arrangements (CSAs). Provided the right systems are in place the buy-side can evidence all of their decisions as to where commission dollars were spent and the sell-side can be adequately rewarded for providing quality research – the better the research it provides, the more commission dollars it attracts.

I wonder if a better approach, then, might be to ensure the whole CSA process is standardised and works properly, since everyone seems happy with it. Otherwise, we will face the worst possible outcome. Firms will have little incentive to invest in proper CSA management systems today if they believe that everything will eventually be fully unbundled. This will do little for industry efficiency and seems to fly squarely in the face of any regulatory objective of transparency. And, at the same time, the whole of the European investment industry will be placed at a competitive disadvantage as the unbundled ‘sticker price’ of their services will appear much higher than that of their competitors in the US or Asia.

Comments
One Response to “If it ain’t broke, break it”
  1. Olof says:

    Spot-on Steve, we are finally getting some traction on CSA’s and the consumer friendly concept combined with more detailed reporting (Level II like) would be more than enough. However, I just met clients coming back from holidays more confused than ever. So much for regulatory clarity… We will have at least a year in total uncertainty on what solution will be required 2017…

Leave a comment

Copyright © 2018 Fidessa group plc. All rights reserved.

The information contained within this website is provided for informational purposes only. Fidessa will use reasonable care to ensure that information is accurate at the time it is made available, and for the duration that it remains on the site. The information may be changed by Fidessa at any time without notice. We also reserve the right to close the website at any time. No representation or warranty, expressed or implied, is given on behalf of Fidessa or any of its respective directors, employees, agents, or advisers as to the accuracy or completeness of the information or opinions contained herein or its suitability for any purpose and, save in the case of fraud, all liability for direct, indirect, special, consequential or other loss or damages of whatever kind that may arise from use of the website is hereby excluded to the fullest extent permitted by law. Any decisions you make based on the information in this website are your sole responsibility and information on the website should not be relied upon in connection with any investment decision.

The copyright of this website belongs to Fidessa. All other intellectual property rights are reserved.

Fragulator® is a registered trademark of Fidessa group plc.

Reproduction or redistribution of this information is prohibited except with written permission from Fidessa.